Trial Profile
Efficacy and Safety Evaluation of Pegamotecan (PEG-Camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2012
Price :
$35
*
At a glance
- Drugs Pegamotecan (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 23 Sep 2005 New trial record.